Immunisation practice and policy.
Open Access
- 1 December 1984
- journal article
- research article
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 38 (4) , 265-269
- https://doi.org/10.1136/jech.38.4.265
Abstract
Immunisation has proved to be a generally safe and effective means of disease control, particularly where environmental approaches are impractical. Recent developments in vaccine production, aimed at selecting or synthesising in pure form the antigens needed to evoke a protective response, give hope of more effective and less toxic vaccines in future. Adequate trials of improved vaccines may, however, be difficult to carry out under modern conditions. Policies for the use of vaccines are sometimes controversial, particularly when there is concern about reactions, as with pertussis vaccine. Acceptance rates for measles and rubella vaccines in the UK have hitherto been disappointingly low and need to be increased if the aims of elimination of measles and congenital rubella are to be achieved. Cost-benefit analyses generally support the use of immunisation in disease control.This publication has 17 references indexed in Scilit:
- Vaccinology of poliomyelitisVaccine, 1984
- DEVELOPMENT OF A PERTUSSIS COMPONENT VACCINE IN JAPANThe Lancet, 1984
- Measles in England and Wales—III: Assessing Published Predictions of the Impact of Vaccination on IncidenceInternational Journal of Epidemiology, 1983
- RATIONAL STRATEGY FOR RUBELLA VACCINATIONThe Lancet, 1983
- Measles immunisation: why have we failed?Archives of Disease in Childhood, 1983
- THE CASE FOR GLOBAL MEASLES ERADICATIONPublished by Elsevier ,1982
- Pertussis vaccine.BMJ, 1981
- Pertussis Vaccine — An Analysis of Benefits, Risks and CostsNew England Journal of Medicine, 1979
- Benefits and costs of the schools' BCG vaccination programme.BMJ, 1976
- Epidemiology in the Global Eradication of SmallpoxInternational Journal of Epidemiology, 1972